| Autor: |
Jakubikova, Michala, Tyblova, Michaela, Tesar, Adam, Magda, Horakova, Daniela, Vlazna, Irena, Rysankova, Iveta, Novakova, Kristyna, Doleckova, Pavel, Dusek, Jiri, Pitha, Stanislav, Vohanka, Josef, Bednarik |
| Předmět: |
|
| Zdroj: |
European Journal of Neurology; Jan2022, Vol. 29 Issue 1, pe7-e8, 2p |
| Abstrakt: |
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. FVC is considered to be a basic indicator of the outcome of COVID-19 because shortness of breath is one of the major persistent predominating symptoms in post-COVID-19 patients. To date, we have already registered 171 confirmed myasthenia gravis (MG) patients with COVID-19 infection, so at present this patient cohort is practically twice the original set. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text